Effects of extended-release niacin with laropiprant in high-risk patients

Martin J Landray, Richard Haynes, Jemma C Hopewell, Sarah Parish, Theingi Aung, Joseph Tomson, Karl Wallendszus, Martin Craig, Lixin Jiang, Rory Collins, Jane Armitage, HPS2-THRIVE Collaborative Group

Research output: Contribution to journalJournal articleResearchpeer-review

924 Citations (Scopus)
Original languageEnglish
JournalThe New England Journal of Medicine
Issue number3
Pages (from-to)203-212
Number of pages10
Publication statusPublished - 17 Jul 2014


  • Aged
  • Atherosclerosis
  • Cholesterol, LDL
  • Delayed-Action Preparations
  • Diabetes Mellitus
  • Double-Blind Method
  • Drug Combinations
  • Female
  • Follow-Up Studies
  • Hemorrhage
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Hypercholesterolemia
  • Hypolipidemic Agents
  • Indoles
  • Infection
  • Male
  • Middle Aged
  • Musculoskeletal Diseases
  • Niacin
  • Risk Factors
  • Treatment Failure

Fingerprint Dive into the research topics of 'Effects of extended-release niacin with laropiprant in high-risk patients'. Together they form a unique fingerprint.

Cite this